Zaire Ebola vaccine candidates
Scope
Date
~
-
Pension funds
NPS shortlists 6 candidates for chief investment officer opening
National Pension Service (NPS) of South Korea, the world’s third-largest pension fund managing 896.6 trillion won ($690.5 billion) as of end-S...
Dec 01, 2022 (Gmt+09:00)
-
Business & Politics
Tesla’s Musk names Korea among top candidate sites for Gigafactory
Tesla Inc. Chief Executive Elon Musk said on Wednesday that South Korea is among its top candidates to build in Asia another Gigafactory, the US ele...
Nov 23, 2022 (Gmt+09:00)
-
Pension funds
NPS narrows search for new CIO to two major candidates
South Korea’s National Pension Service (NPS), the world’s third-largest pension fund managing 917.2 trillion won ($692 billion) in asset...
Nov 16, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Lotte Card draws bid from Hana as key candidates back off
South Korea's Lotte Card Co. has drawn preliminary bids from Hana Financial Group, a leading banking group in the country, and two to three unidenti...
Sep 07, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Leadership & Management
Hyundai Mobis CEO runs for ISO president as first Korean candidate
Hyundai Mobis Co. CEO Cho Sung-hwan has registered as a candidate for the next presidential election of the International Organization for Standar...
Jun 21, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Elec. proposes global research for 6G frequencies
Samsung Electronics Co., South Korea’s tech behemoth, has put forward global research on 6G service frequencies as it aims to take the lead in...
May 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Korean biotech startup signs license deal with US firm
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Feb 17, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
IPOs
Viva Republica poised to become Korea’s fourth decacorn
Viva Republica Inc., the operator of fintech platform Toss, is revving up for a pre-IPO. When finalized, the company will become South Korea’s...
Feb 02, 2022 (Gmt+09:00)
-
Digital assets
Presidential candidates vow to legislate digital assets
Ahead of the 20th presidential election slated for March 9, candidates from both parties have vowed to legislate and systemize digital assets if ele...
Jan 20, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Business & Politics
Jay Y. Lee meets Verizon CEO and Moderna co-founder
Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...
Nov 18, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung heir Lee on US trip for foundry investment, COVID vaccines
Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to f...
Nov 14, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
Pre-IPOs
GIC, EQT, MBK compete for ADT Caps' $300 mn shares
Singapore's sovereign wealth fund GIC, Sweden-based EQT Partners and South Korea-based MBK Partners are among the four shortlisted bidders for share...
Oct 19, 2021 (Gmt+09:00)
-
Moderna co-founder
Giving away patents not in line with capitalist society
WASHINGTON D.C. -- US-based biotechnology company Moderna Inc. wasn’t a household name until the beginning of last year, when its fate changed...
Oct 12, 2021 (Gmt+09:00)
-
Korean chipmakers
Taylor city in Texas likely to host Samsung’s new US chip plant
The global semiconductor industry is keeping a close eye on whether Taylor, a city located in Williamson County of Texas and the most probable site ...
Sep 23, 2021 (Gmt+09:00)
-
Asia’s Covid-19 Success Stories Warily Ponder Post-Vaccination Moves
Earlier this month, Singapore reached a Covid-19 milestone: The fully vaccinated portion of the population crossed 80%. But instead of moving ahead wi...
Sep 15, 2021 (Gmt+09:00)
-
Pharmaceuticals
Medytox’s US business outlook dim as contract with AbbVie ends
South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...
Sep 09, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Strategic buyers line up for IMM-led $1.3 bn Hanssem deal
LX Hausys Ltd., South Korea's leading building materials maker, on Monday announced a plan to join Seoul-based IMM Private Equity in acquiring a con...
Sep 06, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language